NXLIW

Nexalin Technologies (NXLIW)

Nexalin Technologies Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NXLIW

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/01/31	07 : 15	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:NXLIW	Nexalin Technologies Inc
2025/01/30	07 : 26	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	NASDAQ:NXLIW	Nexalin Technologies Inc
2025/01/30	07 : 25	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	NASDAQ:NXLIW	Nexalin Technologies Inc
2025/01/25	06 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXLIW	Nexalin Technologies Inc
2025/01/24	01 : 00	GlobeNewswire Inc.	Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23	NASDAQ:NXLIW	Nexalin Technologies Inc
2025/01/14	22 : 30	GlobeNewswire Inc.	Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025	NASDAQ:NXLIW	Nexalin Technologies Inc
2025/01/11	06 : 35	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/12/24	00 : 00	GlobeNewswire Inc.	Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/12/21	02 : 35	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/11/27	00 : 00	GlobeNewswire Inc.	New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/11/11	22 : 00	GlobeNewswire Inc.	Nexalin Technology CEO Provides Letter to Shareholders	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/11/09	06 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/11/02	03 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/11/02	03 : 00	GlobeNewswire Inc.	Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/11/01	23 : 34	GlobeNewswire Inc.	Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/10/30	23 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/10/28	21 : 30	GlobeNewswire Inc.	Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/10/23	03 : 15	GlobeNewswire Inc.	Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/10/17	21 : 30	GlobeNewswire Inc.	New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/10/14	21 : 30	GlobeNewswire Inc.	Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/10/03	03 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/09/20	05 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/09/05	22 : 00	GlobeNewswire Inc.	Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/07/18	21 : 30	GlobeNewswire Inc.	Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/07/02	03 : 45	GlobeNewswire Inc.	Nexalin Technology Announces Closing of $5.2 Million Public Offering	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/06/28	10 : 15	GlobeNewswire Inc.	Nexalin Technology Announces Pricing of $5.2 Million Public Offering	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/06/26	22 : 00	GlobeNewswire Inc.	Nexalin Technology Announces Positive Clinical Study Data in Major Depressive Disorder and Publication of Clinical Trial Results in Leading Scientific Journal	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/06/20	21 : 30	GlobeNewswire Inc.	Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/06/19	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NXLIW	Nexalin Technologies Inc
2024/06/14	22 : 53	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:NXLIW	Nexalin Technologies Inc